Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
about
Expression of fibroblast specific protein-1 in pleural tuberculosis and its clinical biological significance.Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expression.Areca nut components stimulate ADAM17, IL-1α, PGE2 and 8-isoprostane production in oral keratinocyte: role of reactive oxygen species, EGF and JAK signaling.Immunohistochemical Localization of Epithelial Mesenchymal Transition Markers in Cyclosporine A Induced Gingival OvergrowthProteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis.Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.Aberrant SSEA-4 upregulation mediates myofibroblast activity to promote pre-cancerous oral submucous fibrosisGlabridin inhibits the activation of myofibroblasts in human fibrotic buccal mucosal fibroblasts through TGF-β/smad signaling.Inhibitory effect of GMI, an immunomodulatory protein from Ganoderma microsporum, on myofibroblast activity and proinflammatory cytokines in human fibrotic buccal mucosal fibroblasts.STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.Arecoline stimulated early growth response-1 production in human buccal fibroblasts: suppression by epigallocatechin-3-gallate.
P2860
Q33686665-7F4B198A-36FE-4ACA-BBE4-2E31CA8E5CC1Q37022129-485D6EBF-EE30-470A-B83B-DF01E677C941Q37086148-C09E4F97-1843-48E4-9E7C-2C7CEB2BE66AQ37266599-B82EBBE5-1905-492C-88C2-E3CAC4649DA0Q37645025-D29E25FE-212E-4AA9-878F-22985F2282A1Q37724033-4E809775-80D1-4C2F-BAC8-8AB05F3BE93DQ42368725-E4C34067-F2F3-4CAE-BDEE-17469E4DE783Q47422409-2908DD54-E5EF-451F-9A16-F18EAE34431DQ47688363-E44B7205-1709-425A-9B20-A2225671AFCAQ48170188-DD8E97D9-AAC4-4793-A4AB-2753C83E5BF9Q51686566-C5C6C748-96D7-4B41-AE3C-6331EBBF7978Q54383842-7E55E3AF-02C9-4987-878B-2F28F5AD374B
P2860
Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@ast
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@en
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@nl
type
label
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@ast
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@en
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@nl
prefLabel
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@ast
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@en
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@nl
P2093
P2860
P1433
P1476
Elevation of S100A4 expression ...... is of oral submucous fibrosis.
@en
P2093
Cheng-Chia Yu
Chung-Hung Tsai
Hsin-I Hsu
Yu-Chao Chang
P2860
P304
P356
10.1371/JOURNAL.PONE.0055122
P407
P577
2013-01-31T00:00:00Z